Incretin hormone agonists: Current and emerging pharmacotherapy for obesity management
The constant mental noise around food has become exhausting
Access comprehensive market data, trends, and forecasts in one downloadable databook: Market Overview: Novel Use in Different Areas A class of drugs used in the management of type 2 diabetes and obesity is called GLP-1 receptor agonists
Patient advocacy organizations work to increase awareness of obesity as chronic disease requiring sustained medical management
Clinical trials show Mounjaro produced up to 22.5% weight loss, compared with Wegovy's 15% average, though individual responses vary significantly, regardless of which medication shows higher efficacy in controlled studies
The recent NEJM findings suggest GLP-1 pills can provide health improvements that are directly in line with what weve seen in the other injectable GLP-1 receptor agonists, says Matthew Cavender, a study co-author and a cardiologist at the University of North Carolina School of Medicine